News Releases










08 November 2023
Cronos Group Reports 2023 Third Quarter Results
Industry-leading balance sheet with $840 million in cash and short-term investments Net revenue in Q3 2023 increased by 22% year-over-year to $24.8 million ; on a constant currency basis, net revenue in Q3 2023 increased by 27% year-over-year to $26.0 million Spinach ® was top-10 in retail sales in
30 October 2023
Cronos Unveils its New THCV Products: Spinach FEELZ™ Full Tilt
TORONTO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, announced the launch of two new THCV-infused products; Spinach FEELZ™ Full Tilt THCV vape and gummy. Cronos also plans to launch a THCV-infused pre-roll
05 October 2023
Cronos brand Spinach® Wins Best Pre-Roll at Grow Up Awards
TORONTO, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, is pleased to announce its Spinach® brand won “Best Pre-Roll” at the Grow Up Awards this past Sunday for its Spinach® Fully Charged Atomic GMO infused
18 September 2023
Cronos launches leading medical brand PEACE NATURALS® in Germany
TORONTO, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it shipped its first order of bulk cannabis, which will be sold under the PEACE NATURALS® brand in Germany. In July, Cronos signed a distribution agreement with
08 August 2023
Cronos Group Reports 2023 Second Quarter Results
Industry-leading balance sheet with $841 million in cash and short-term investments Increased 2023 operating expense savings target to $20 to $25 million Announces additional initiatives to streamline supply chain and improve cash flow Spinach ® was top-10 in retail sales in every category it
06 July 2023
Cronos Group Inc. confirms receipt of unsolicited indications of interest
TORONTO, July 06, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today confirmed that it has received a number of unsolicited indications of interest from third parties, each regarding a potential transaction involving Cronos and the third party.
23 June 2023
Cronos Group Inc. Announces Results of 2023 Annual Meeting of Shareholders
TORONTO, June 23, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announces that at its Annual Meeting of Shareholders held yesterday, June 22, 2023 (the “Meeting”), shareholders holding a total of 247,410,987 common shares of the Company voted in
31 May 2023
Cronos Group Announces Streamlined Operating Structure to Improve Cash Flow
Plans to Exit Existing U.S. hemp-derived CBD Operations Intends to Launch Lord Jones ® Brand in the Canadian Adult-use Market in Q4 2023 TORONTO, May 31, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company,
09 May 2023
Cronos Group Reports 2023 First Quarter Results
Industry-leading balance sheet with $836 million in cash and short-term investments Targeting positive cash flow in 2024 Net revenue in Canada increased 6% in Q1 2023 compared to Q1 2022 ; on a constant currency basis net revenue in Canada increased 14% in Q1 2023 compared to Q1 2022 Spinach ® was
28 April 2023
Cronos Group Inc. to Hold Virtual 2023 Annual Meeting of Shareholders
TORONTO, April 28, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2023 Annual Meeting of Shareholders on Thursday, June 22, 2023, at 11:00 a.m. ET. Cronos will be conducting the meeting in a virtual-only format via live audio webcast.
12 April 2023
Cronos Bolsters its Spinach® Infused Pre-roll Portfolio with CBG, CBC and CBN
Spinach ® rose to 8 th place in the pre-roll category, capturing 2.5% market share in Q1 2023, up from 1.4% in Q4 2022 1 In Q1 2023 Spinach ® ranked in the top-10 in all categories it participated in: Flower, Pre-rolls, Vapes and Edibles TORONTO, April 12, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc.
28 February 2023
Cronos Group Reports 2022 Fourth Quarter and Full-Year Results
Consolidated net revenue increased 23% in Full Year 2022 compared to Full Year 2021 ; on a constant currency basis consolidated net revenue increased 28% in Full Year 2022 compared to Full Year 2021 Net revenue in Israel increased 128% in Full Year 2022 compared to Full Year 2021 ; on a constant
08 February 2023
Spinach® Becomes the Number One Edible Brand in January¹
Spinach ® gummies, known for incredible flavors and quality, are winning with adult consumers in the Canadian market TORONTO, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, today announced that its award-winning



Print Page Sign Up for Email Alerts RSS Feeds Financial Tearsheet